Share

Jameela Al Salman

M.D.

Associate Professor of Medicine, Arabian Gulf University

Chief of Medical Staff for Medical Departments in Salmaniya Medical Complex

Chairperson of the hereditary blood diseases , Salmaniya Medical Complex

Senior Consultant in Infectious Diseases, Internal Medicine, and Geriatric Medicine

Dr. Al Salman is an Associate Professor in the Arabian Gulf University and is involved in a wide range of educational and research activities. She published many articles in peer reviewed journals. She led several international, regional, and local committees and quality projects. She is also in editorial Board of the several Medical Journals.


She graduated with Honor from the medical school at Arabian Gulf University. Then she joined the Salmaniya Medical complex in 1996. She holds three American Board certifications: American Board in Internal Medicine, American Board in Geriatric Medicine, American Board in Infectious Diseases. Further, she has the board in infection control and recently the American board in medical quality. Dr. Al Salman has completed her residency and fellowship programs in the United States, where she finished the internal medicine residency in Eason, Hahnemann University, Pennsylvania, USA. Then she did a fellowship in geriatric medicine at Temple University in Pennsylvania, followed by a fellowship in infectious diseases at Yale University, New Haven, Connecticut, USA.


She is a member of the Strategic and Technical Advisory Group for Antimicrobial resistance (STAG-AMR) which is the principal advisory group to the World Health Organization (WHO) on antimicrobial resistance, and a member of WHO Infection control and prevention development guidelines for COVID-19. She has received several awards locally, regional, and internationally for her scientific contribution.

- Awarded by His Majesty the King for her achievements in improving the clinical services and for the achievement in the antibiotic stewardship program and received the medal of competency from the first degree from his majesty in the national day of the kingdom December 2016.

-  Awarded the first position for Prize Khalifa Bin Salman Al Khalifa the prime minister in Bahrain in its first version for Bahraini Doctor for the achievements in medical research and innovation 2020.

- Awarded for excellence award for Arabic women in medical field for 2020 from League of Arab states.

- Awarded for the program of antibiotic stewardship for the best governmental practices for 2016 by HE the prime Minister in kingdom of Bahrain in 2016.

Jameela Al Salman

M.D.

Associate Professor of Medicine, Arabian Gulf University

Chief of Medical Staff for Medical Departments in Salmaniya Medical Complex

Chairperson of the hereditary blood diseases , Salmaniya Medical Complex

Senior Consultant in Infectious Diseases, Internal Medicine, and Geriatric Medicine

Dr. Al Salman is an Associate Professor in the Arabian Gulf University and is involved in a wide range of educational and research activities. She published many articles in peer reviewed journals. She led several international, regional, and local committees and quality projects. She is also in editorial Board of the several Medical Journals.


She graduated with Honor from the medical school at Arabian Gulf University. Then she joined the Salmaniya Medical complex in 1996. She holds three American Board certifications: American Board in Internal Medicine, American Board in Geriatric Medicine, American Board in Infectious Diseases. Further, she has the board in infection control and recently the American board in medical quality. Dr. Al Salman has completed her residency and fellowship programs in the United States, where she finished the internal medicine residency in Eason, Hahnemann University, Pennsylvania, USA. Then she did a fellowship in geriatric medicine at Temple University in Pennsylvania, followed by a fellowship in infectious diseases at Yale University, New Haven, Connecticut, USA.


She is a member of the Strategic and Technical Advisory Group for Antimicrobial resistance (STAG-AMR) which is the principal advisory group to the World Health Organization (WHO) on antimicrobial resistance, and a member of WHO Infection control and prevention development guidelines for COVID-19. She has received several awards locally, regional, and internationally for her scientific contribution.

- Awarded by His Majesty the King for her achievements in improving the clinical services and for the achievement in the antibiotic stewardship program and received the medal of competency from the first degree from his majesty in the national day of the kingdom December 2016.

-  Awarded the first position for Prize Khalifa Bin Salman Al Khalifa the prime minister in Bahrain in its first version for Bahraini Doctor for the achievements in medical research and innovation 2020.

- Awarded for excellence award for Arabic women in medical field for 2020 from League of Arab states.

- Awarded for the program of antibiotic stewardship for the best governmental practices for 2016 by HE the prime Minister in kingdom of Bahrain in 2016.

Recent Publications

A Systematic Literature Review on Pre-exposure Prophylaxis as a Strategy for HIV Risk Reduction in the Middle East

Published On 2025 Apr 21

Journal article

Pre-exposure prophylaxis (PrEP) has emerged as a crucial tool in HIV prevention globally, yet its implementation in the Middle East and North Africa (MENA) region faces unique challenges. PrEP is expected to be effective in reducing HIV transmission. However, there is limited comprehensive data about its awareness, utilization, and effectiveness within MENA countries. The region's distinct cultural, social, and healthcare system characteristics create specific barriers that must be addressed....


The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance

Published On 2025 Apr 17

Journal article

BACKGROUND: The 2017 WHO Bacterial Priority Pathogens List (BPPL) has been instrumental in guiding global policy, research and development, and investments to address the most urgent threats from antibiotic-resistant pathogens, and it is a key public health tool for the prevention and control of antimicrobial resistance (AMR). Since its release, at least 13 new antibiotics targeting bacterial priority pathogens have been approved. The 2024 WHO BPPL aims to refine and build on the previous list...